Preparation and Immunogenicity Prediction of Brucella melitensis mRNA Vaccine Candidate Based on omp16 and omp19 Genes
Vaccines · 05.03.2026 · 14 (3) · 240
DOI: 10.3390/vaccines14030240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 05.03.2026. Verfasst von Jingjie Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010110, China. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Inner Mongolia Autonomous Region, High-Level Clinical Specialty Development Science and Technology Project for Public Hospitals in the Capital Region, General Program of Inner Mongolia Medical University.
Abstract (Originalsprache)
Background
Brucella outer membrane proteins (Omps) are an important part of its cell wall and major virulence-related factors. Omp16 and Omp19 proteins are the advantageous antigens of Brucella and have been widely used in research on vaccines against brucellosis. As an emerging vaccine, the mRNA vaccine has unique advantages in the fight against intracellular parasitic bacteria.
Methods
In this study, mRNA encoding the omp16 and omp19 genes of Brucella. melitensis (B. melitensis) was synthesized using in vitro transcription. The target mRNA was transfected into HEK 293T cells to evaluate protein expression levels and assess its immunogenicity. Finally, bioinformatic approaches were employed to analyze potential antigenic epitopes.
Results
In this study, the successfully constructed recombinant plasmids pIVTRup-omp16 and pIVTRup-omp19 were utilized to synthesize omp16-mRNA and omp19-mRNA, each approximately 600 nt in length. Western blot analysis detected the expression of proteins with molecular weights of 16 kDa and 19 kDa in HEK 293T cells at 24 h post-transfection with mRNA. Purified rOmp16 and rOmp19 had good immunogenicity, which could specifically bind to serum antibodies of brucellosis patients. rOmp16 had stronger immunogenicity than rOmp19. Epitope prediction showed that Omp16 contained seven epitopes and Omp19 contained six epitopes. In addition, Omp16 and Omp19 could form stable complexes with target receptors. Simulated immunization with Omp16 and Omp19 proteins significantly activated both CD4+ and CD8+ T cells.
Conclusions
The immunogenic proteins were successfully expressed in cells based on the mRNA fragments synthesized from omp16 and omp19 genes of B. melitensis, which was a preliminary exploration for the preparation of B. melitensis mRNA vaccine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010110, China.
- National and Local Joint Engineering Research Center of Modern Mongolian Medicine Research and Testing, International Mongolian Hospital of Inner Mongolia, Hohhot 010065, China.
- School of Chemistry & Chemical Engineering, Inner Mongolia University, Hohhot 010020, China.
- Department of Basic Medicine, Inner Mongolia Medical University, Hohhot 010110, China.
- Department of Clinical Laboratory, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010110, China.
ORCID-Profile: Jingjie Zhang, Dezhi Yang
Förderung
- Natural Science Foundation of Inner Mongolia Autonomous Region
- High-Level Clinical Specialty Development Science and Technology Project for Public Hospitals in the Capital Region
- General Program of Inner Mongolia Medical University
- Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences
Zitieren
APA
Zhang, J., Borijihan, H., Chen, Y., Baigude, H., Bao, L., Quan, F., & Yang, D. (2026). Preparation and Immunogenicity Prediction of Brucella melitensis mRNA Vaccine Candidate Based on omp16 and omp19 Genes. Vaccines, 14(3), 240. https://doi.org/10.3390/vaccines14030240
Vancouver
Zhang J, Borijihan H, Chen Y, Baigude H, Bao L, Quan F, et al. Preparation and Immunogenicity Prediction of Brucella melitensis mRNA Vaccine Candidate Based on omp16 and omp19 Genes. Vaccines. 2026;14(3):240. doi:10.3390/vaccines14030240
BibTeX
@article{Zhang2026,
author = {Zhang, Jingjie and Borijihan, Haiyan and Chen, Yixuan and Baigude, Huricha and Bao, Lili and Quan, Fu and Yang, Dezhi},
title = {Preparation and Immunogenicity Prediction of Brucella melitensis mRNA Vaccine Candidate Based on omp16 and omp19 Genes},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {3},
pages = {240},
doi = {10.3390/vaccines14030240}
}
EUVIMED